General Information of This Metabolic Reaction (MR) (ID:
MR002988) |
Formula |
|
Reactant |
Alitretinoin |
Product |
4-oxo-9-cis-retinoic acid |
Reactant Info
|
Product Info
|
Metabolic Enzyme
|
Cytochrome P450 2C9 (CYP2C9)
|
DME Info
|
Cytochrome P450 3A4 (CYP3A4)
|
DME Info
|
Cytochrome P450 1A1 (CYP1A1)
|
DME Info
|
Cytochrome P450 1A2 (CYP1A2)
|
DME Info
|
Metabolic Type
|
Unclear
-
Unclear
|
|
|
|
|
|
|
|
Other MR(s) Related to The Reactant of This MR |
Other MR(s) That Metabolize The Reactant of This MR
|
|
Other MR(s) Related to The Product of This MR |
Other MR(s) That Produce The Product of This MR
|
|
References |
1 |
The single-dose pharmacokinetics of alitretinoin and its metabolites are not significantly altered in patients with cirrhosis Br J Dermatol. 2014 Feb;170(2):408-14. doi: 10.1111/bjd.12546.
|
2 |
DailyMed : Alitretinoin
|
3 |
Human cytochrome P450s involved in the metabolism of 9-cis- and 13-cis-retinoic acids
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.